Low-dose total skin electron beam therapy as a debulking agent for cutaneous T-cell lymphoma: an open-label prospective phase II study

2012 ◽  
Vol 166 (2) ◽  
pp. 399-404 ◽  
Author(s):  
M.R. Kamstrup ◽  
L.M. Lindahl ◽  
R. Gniadecki ◽  
L. Iversen ◽  
L. Skov ◽  
...  
Keyword(s):  
Electron Beam ◽  
T Cell ◽  
Phase Ii ◽  
Low Dose ◽  
Phase Ii Study ◽  
Cell Lymphoma ◽  
Cutaneous T Cell Lymphoma ◽  
Open Label ◽  
Electron Beam Therapy ◽  
Prospective Phase

A multicenter, open label, phase II study to assess the efficacy and safety of APO866 in the treatment of patients with refractory or relapsed cutaneous T-cell lymphoma.

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. e20044-e20044
Author(s):  
Simone M. Goldinger ◽  
Sharon Gobbi ◽  
Michelle Ding ◽  
Anna Lisa Frauchiger ◽  
Regina Fink-Puches ◽  
...  
Keyword(s):  
T Cell ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Cell Lymphoma ◽  
T Cell Lymphoma ◽  
Cutaneous T Cell Lymphoma ◽  
Efficacy And Safety ◽  
Open Label ◽  
Open Label Phase

scholarly journals Low-Dose Hypofractionated Total Skin Electron Beam Therapy for Adult Cutaneous T-Cell Lymphoma

2020 ◽  
Vol 10 (6) ◽  
pp. e529-e537 ◽  
Author(s):  
Elizabeth B. Jeans ◽  
Yue-Houng Hu ◽  
Bradley J. Stish ◽  
Brian King ◽  
Mark Davis ◽  
...  
Keyword(s):  
Electron Beam ◽  
T Cell ◽  
Low Dose ◽  
Cell Lymphoma ◽  
T Cell Lymphoma ◽  
Cutaneous T Cell Lymphoma ◽  
Electron Beam Therapy
Sign in / Sign up

Export Citation Format

Share Document